1. Home
  2. WAT vs BWXT Comparison

WAT vs BWXT Comparison

Compare WAT & BWXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAT
  • BWXT
  • Stock Information
  • Founded
  • WAT 1958
  • BWXT 1867
  • Country
  • WAT United States
  • BWXT United States
  • Employees
  • WAT N/A
  • BWXT N/A
  • Industry
  • WAT Biotechnology: Laboratory Analytical Instruments
  • BWXT
  • Sector
  • WAT Industrials
  • BWXT
  • Exchange
  • WAT Nasdaq
  • BWXT Nasdaq
  • Market Cap
  • WAT 17.4B
  • BWXT 15.4B
  • IPO Year
  • WAT 1995
  • BWXT N/A
  • Fundamental
  • Price
  • WAT $330.86
  • BWXT $202.55
  • Analyst Decision
  • WAT Buy
  • BWXT Buy
  • Analyst Count
  • WAT 15
  • BWXT 10
  • Target Price
  • WAT $373.13
  • BWXT $161.95
  • AVG Volume (30 Days)
  • WAT 800.4K
  • BWXT 1.2M
  • Earning Date
  • WAT 11-04-2025
  • BWXT 11-03-2025
  • Dividend Yield
  • WAT N/A
  • BWXT 0.49%
  • EPS Growth
  • WAT 10.77
  • BWXT 9.94
  • EPS
  • WAT 11.09
  • BWXT 3.21
  • Revenue
  • WAT $3,046,056,000.00
  • BWXT $2,864,520,000.00
  • Revenue This Year
  • WAT $7.15
  • BWXT $17.25
  • Revenue Next Year
  • WAT $6.34
  • BWXT $9.50
  • P/E Ratio
  • WAT $30.05
  • BWXT $63.07
  • Revenue Growth
  • WAT 5.89
  • BWXT 10.13
  • 52 Week Low
  • WAT $275.05
  • BWXT $84.21
  • 52 Week High
  • WAT $423.56
  • BWXT $204.79
  • Technical
  • Relative Strength Index (RSI)
  • WAT 62.02
  • BWXT 72.92
  • Support Level
  • WAT $319.34
  • BWXT $190.00
  • Resistance Level
  • WAT $338.37
  • BWXT $199.72
  • Average True Range (ATR)
  • WAT 9.43
  • BWXT 6.55
  • MACD
  • WAT 2.07
  • BWXT 1.16
  • Stochastic Oscillator
  • WAT 86.04
  • BWXT 68.63

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

About BWXT BWX Technologies Inc.

BWX Technologies Inc is a specialty manufacturer and service provider of nuclear components, operating in two segments: Government Operations and Commercial Operations. The Government Operations segment produces naval nuclear reactors and fuel for the U.S. Naval Nuclear Propulsion Program, while the Commercial Operations segment designs and manufactures commercial nuclear steam generators, heat exchangers, pressure vessels, reactor components, and other auxiliary equipment, including containers for the storage of spent nuclear fuel and other high-level nuclear waste. The majority of the company's revenue comes from Government Operations, with sales principally in the United States, Canada, and other regions.

Share on Social Networks: